HCK antibody

Principal name

HCK antibody

Alternative names for HCK antibody

Hemopoietic cell kinase, p59-HCK, p60-HCK, BMK, p56-HCK, Tyrosine-protein kinase HCK, B-cell/myeloid kinase

SwissProt ID

P08103 (Mouse), P08631 (Human), P50545 (Rat), Q9H5Y5 (Human)

Gene ID

3055 (HCK), 15162 (Hck)

Available reactivities

Hu (Human), Ms (Mouse), Rt (Rat), Mky (Monkey), Bov (Bovine), Can (Canine), Eq (Equine), GP (Guinea Pig), Rb (Rabbit)

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Paraffin Sections (P), Flow Cytometry (F)

Background of HCK antibody

Hck (hemopoietic cell kise) is a protein tyrosine kise of the Src family prominently expressed in the lymphoid and myeloid lineages of hemopoiesis. It participates in transducing a variety of extracellular sigls, which ultimately affect cellular processes including proliferation, differentiation and migration.The well-defined modular structure of Hck comprises a relatively divergent, NH2-termil "unique" domain, which is subject to post-translatiol lipid modifications thereby targeting Hck to the plasma membrane. Src homology 3 (SH3) and 2 (SH2) domains, and a tyrosine kise catalytic domain follow the "unique" domain. The catalytic activity of Hck is regulated, both positively and negatively, by tyrosine phosphorylation of highly conserved tyrosine (Y) residues. Phosphorylation of a single conserved Tyr499 residue in the COOH terminus of Hck by the protein kise Csk renders Hck ictive as a result of an intramolecular interaction between the phosphorylated tyrosine (pY) residue and its own SH2 domain. Disruption of this interaction, either as a result of dephosphorylation, or substitution of the COOH-termil regulatory Y residue with phenylalanine (F; e.g., HckY499F), or COOH-termil truncation mutations as observed in the virally transduced v-Src oncoprotein, results in constitutive activation of Hck. In contrast to phosphorylation of the COOH-termil regulatory tyrosine residue, autophosphorylation of a tyrosine residue (Tyr388) within the kise domain of Hck acts to positively regulate its catalytic activity. Thus, activation of Hck requires both disruption of the COOH-termil regulatory tyrosine-SH2 domain interaction and autophosphorylation of the regulatory tyrosine residue within the kise domain. The dysfunction or dysregulation of Hck may contribute to the pathogenesis of some human leukemias.

Items 21 to 28 of 28 total

per page
Page:
  1. 1
  2. 2

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, HCK (mGFP-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 4, 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (mGFP-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 4, 200 uL, >10^7 TU/mL  
200 µl / €1,164.00
  OriGene Technologies, Inc.

Lenti ORF particles, HCK (Myc-DDK tagged) - Human hemopoietic cell kinase (HCK), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (Myc-DDK tagged) - Human hemopoietic cell kinase (HCK), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €969.00
  OriGene Technologies, Inc.

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €969.00
  OriGene Technologies, Inc.

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €969.00
  OriGene Technologies, Inc.

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €1,041.00
  OriGene Technologies, Inc.

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 4, 200 uL, >10^7 TU/mL

Lenti ORF particles, HCK (Myc-DDK-tagged)-Human hemopoietic cell kinase (HCK), transcript variant 4, 200 uL, >10^7 TU/mL  
200 µl / €1,041.00
  OriGene Technologies, Inc.

Mouse Lenti ORF Particles

Catalog No.    

Lenti ORF particles, Hck (GFP-tagged) - Mouse hemopoietic cell kinase (Hck), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, Hck (GFP-tagged) - Mouse hemopoietic cell kinase (Hck), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €1,185.00
  OriGene Technologies, Inc.

Lenti ORF particles, Hck (Myc-DDK-tagged) - Mouse hemopoietic cell kinase (Hck), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, Hck (Myc-DDK-tagged) - Mouse hemopoietic cell kinase (Hck), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €1,061.00
  OriGene Technologies, Inc.

Items 21 to 28 of 28 total

per page
Page:
  1. 1
  2. 2
  • LinkedIn